4//SEC Filing
Scanlan Sean F. 4
Accession 0001209191-24-001589
CIK 0001630627other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 9:00 PM ET
Size
7.9 KB
Accession
0001209191-24-001589
Insider Transaction Report
Form 4
Scanlan Sean F.
Chief Innovation Officer
Transactions
- Award
Common Stock
2024-01-10+65,025→ 97,209 total - Award
Stock Option (Right to Buy)
2024-01-10+73,200→ 73,200 totalExercise: $13.46Exp: 2034-01-10→ Stock Option (Right to Buy) (73,200 underlying)
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date.
- [F2]Includes 96,070 RSUs.
- [F3]The stock option vests in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028, subject to Reporting Person's providing continued service to Issuer through each vesting date.
Documents
Issuer
TREACE MEDICAL CONCEPTS, INC.
CIK 0001630627
Entity typeother
Related Parties
1- filerCIK 0001856371
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 9:00 PM ET
- Size
- 7.9 KB